Stock Movers: Rheinmetall Falls, Stellantis Rises, Argenx Faces Setback

European Defense Stocks Decline

• 📉 Rheinmetall and other European defense stocks like Henold and Leonardo are falling due to progress in Ukraine peace talks.
• 💡 The focus of negotiations is on security guarantees, with Ukraine potentially accepting bilateral guarantees instead of NATO membership, signaling good progress.
• ⚠️ Despite potential peace, defense spending may not cease, but market correlation shows weakness in defense stocks with peace news.

Automaker Stocks and EU Regulations

• 🚗 Stellantis and other European automakers may see a breather as the EU considers softening rules on combustion engine cars.
• 🗓️ The EU is contemplating extending the 2035 ban on new combustion engine vehicles by five years or removing it entirely, allowing a longer transition to emission-free driving.
• ⚡ This regulatory adjustment could help European carmakers remain competitive but risks slowing the development of green technologies and widening the gap with US companies like Tesla.

Argenx Drug Trial Setback

• 🔬 Argenx, a Dutch biotech company, has encountered a significant setback with its flagship drug.
• 💔 Studies evaluating the drug for thyroid eye disease in adults have been discontinued, ruling out a potential patient population of 100,000 in the US.
• 📈 This discontinuation pressures sales ambitions for 2030 and increases scrutiny on other upcoming trial results.
• 💰 Despite the setback, some analysts view the current share price weakness as a buying opportunity, citing strong underlying fundamentals.